Vaginal trichomoniasis is associated with symptoms of yellow discharge, abnormal vaginal odor, and vulvar itching, but more sensitive tests like culture and immunofluorescent staining are needed for improved detection and control.

Clinical manifestations of vaginal trichomoniasis.

Trichomoniasis treatment challenges include understanding the mechanisms of resistance to 5-nitroimidazole drugs, developing new treatments, and addressing the impact of trichomoniasis on public health.

Trichomonas vaginalis: treatment questions and challenges

Trichomonas vaginalis is a global health concern with increasing incidence and complexity in diagnosis, and new diagnostic options like nucleic acid amplification tests show promise for single-visit testing and treatment.

Trichomonas vaginalis: Clinical relevance, pathogenicity and diagnosis

Trichomoniasis is a sexually transmitted infection that can cause vaginal discharge, pain, and discomfort in both men and women, and can coexist with chlamydia, gonorrhoea, and HIV.

Dealing with trichomoniasis.

Trichomonas vaginalis is a urogenital pathogen in men, with potential for nongonococcal urethritis and prostatitis, and current recommendations for evaluation and treatment should be reassessed.

Clinical Manifestations of Trichomoniasis in Men

Trichomonas vaginalis infection can be effectively treated with single-dose antibiotics, but women with HIV should receive 7 days of therapy.

A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.

Specific IgG subclass response in vaginal secretions may play a significant role in establishing symptomatic infection in female patients with Trichomonas vaginalis infection.

Antitrichomonas IgG, IgM, IgA, and IgG subclass responses in human intravaginal trichomoniasis

Trichomoniasis is a sexually transmitted infection with potential for transmission and acquisition of HIV, and screening for the disease is important.

Trichomoniasis: clinical manifestations, diagnosis and management

Several diagnostic methods can accurately differentiate trichomoniasis infection from other sexually transmitted infections, but current methods mostly use women's urine and vaginal samples, and methods for men's infections are limited.

A Review on Diagnostic Methods for Trichomonas Vaginalis

Trichomonas vaginalis pathogenesis is complex and involves adhesion, hemolysis, and soluble factors, requiring further research for improved disease control and prevention.

Clinical and Microbiological Aspects ofTrichomonas vaginalis

Continuing education for providers is needed to improve screening, treatment, and retesting and retreatment of trichomoniasis in HIV-positive patients and the general population.

Survey of Obstetrician-gynecologists in the United States About Trichomoniasis, 2016

Trichomoniasis is a common sexually transmitted disease with potential serious complications, but little research is devoted to its control and its potential impact on public health.

Trichomoniasis

Trichomoniasis is strongly associated with pelvic inflammatory illness, with mucopurulent discharge being a significant clinical trait in adult females with PID.

Some Clinical Features of Trichomoniasis Associated with Pelvic Organs Tenderness in Sample of Iraqi women

Trichomoniasis unresponsive to 5-nitroimidazole therapy can be effectively treated with a low-cost intravaginal combination of boric acid and clotrimazole cream in resource-limited countries.

Trichomoniasis refractory to 5-nitroimidazole therapy in Trinidad

Trichomonas vaginalis is a significant consideration in sexually active men with urethral symptoms or inflammation but little or no evidence of discharge on physical examination.

Trichomoniasis in Men: Old Issues and New Data

Trichomoniasis infection rates in US males are lower than in women, with higher rates in black men, HSV-2 infection, and other factors associated with sexually transmitted infections.

Prevalence of Trichomonas vaginalis Infection Among US Males, 2013–2016

The global prevalence of Trichomonas vaginalis is 16% in female sex workers, with the highest incidence in African and low-income countries.

Global prevalence of Trichomonas vaginalis among female sex workers: a systematic review and meta-analysis

Trichomoniasis is a significant sexually transmitted infection with potential adverse health outcomes for both sexes, and diagnostic efforts beyond traditional sexually transmitted disease clinic settings are needed.

Trichomoniasis: under control or undercontrolled?

Lactobacillus gasseri's aggregation-promoting factor APF-2 effectively inhibits Trichomonas vaginalis adhesion to human vaginal ectocervical cells, potentially benefiting new therapeutic strategies.

A Cell Surface Aggregation-Promoting Factor from Lactobacillus gasseri Contributes to Inhibition of Trichomonas vaginalis Adhesion to Human Vaginal Ectocervical Cells

These studies suggest that the symptoms of trichomoniasis include vaginal discharge, abnormal vaginal odor, vulvar itching, pain, and discomfort.